If you’re weary of constantly hunting hot-story stocks and would rather just simplify your stock picking, you’re in luck. You don’t have to sacrifice performance by minimizing your trading activity, you only have to pick the right stocks to buy and hold for the long haul.
Three familiar stock names fit this bill quite well. Here’s a closer look at Edwards Lifesciences (NYSE: EW), Texas Instruments (NASDAQ: TXN), and Nike (NYSE: NKE), each of which is an unstoppable stock in its own unique way.
1. Edwards Lifesciences
Edwards Lifesciences has much to offer the medical community, from heart valves to blood management solutions to oxygen sensors to vessel repair patches (and more). And the medical community continues to buy the company’s goods in a big way. In only one quarter since 2006 has Edwards posted lower year-over-year quarterly revenue, and that was in the second quarter of 2020, the height of the COVID-19 pandemic.
And yet that headwind was still overcome beginning the very next quarter. Operating income growth has been almost as reliable. These aren’t petty improvements either. Double-digit growth is the norm here and expected to remain the norm for the foreseeable future. Analysts collectively expect top-line growth of nearly 11% for 2022, pumping up what will likely be 2021 per-share earnings of $2.26 to $2.58, a 14% increase. Chalk it up to a combination of the nature of the business and Edwards Lifesciences’ know-how.
See, consumers may skip a shopping trip or postpone a vacation, but they typically don’t put off medical care, particularly when an insurance company is footing the bulk of the bill (as is typically the case with Edwards’ products). The company is also more than able to hold its place as a go-to name in the business as well, with lots of innovation and ongoing improvements of its existing product portfolio.
For instance, it recently won the FDA’s approval for the use of its SAPIEN 3 transcatheter valve with its Alterra adaptive pre-stent for patients with severe pulmonary regurgitation. In short, the combination will allow the SAPIEN 3 to be utilized in pulmonic heart valve replacement procedures.
The company’s recently published growth strategy suggests its business could double in size by 2028. And, given its growth trends to date, there’s little reason to doubt that outlook.
2. Texas Instruments
Most people probably know Texas Instruments as a brand name for basic office electronics like calculators, while a few investors may also recognize …….